FDA Warning Letter — AACE Pharmaceuticals, Inc.
The FDA took a Warning Letter action against AACE Pharmaceuticals, Inc. on May 13, 2025 (Fairfield, NJ). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- AACE Pharmaceuticals, Inc.
- Date
- May 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Fairfield, NJ (United States)